<DOC>
	<DOC>NCT02548364</DOC>
	<brief_summary>To study the effect of calcifediol on left ventricular remodeling, mineral metabolism, plasma levels of several prognostic biomarkers and on endothelial function after an anterior myocardial infarction.</brief_summary>
	<brief_title>Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ventricular Remodeling</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcifediol</mesh_term>
	<criteria>Age â‰¥ 40 years and maximum 85 years. Anterior myocardial infarction Sign informed consent Death during the index event Age younger than 40 or older than 85 years Previous Infarction More than 7 days in hospitalization Systemic inflammatory or autoimmune disease Concomitant disorders limiting survival Concomitant cardiomyopathy Left ventricular hypertrophy &gt; 16mm in females and &gt; 17mm in males eGFR&lt;45 LVEF&lt;30 Incomplete revascularization Valvular prosthesis Aortic stenosis with mean gradient&gt; 25 mmHg Moderate or severe valvular regurgitation Hypersensitivity or intolerance vitamin D supplement o excipient Blood Calcium &gt;10.5 mg/dl Inability to follow. Difficulty in treatment compliance Contraindication for MRI, including indication to place a cardiac device Indication of therapy with vitamin D. Patient desires to take vitamin D. Drugs or conditions that interfere with the pharmacokinetics of calcifediol</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Ventricular remodeling</keyword>
	<keyword>Biomarkers</keyword>
</DOC>